In addition, YAP1 and TAZ could monitor therapy resistance, as elevated YAP1 expression was observed in 5-FU-resistant CRC and EC cell lines cells as well as in doxorubicin-resistant HCC HepG2 and Huh7 cells. The gene discussed is YAP1; the disease is colorectal carcinoma.